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Cx40A96S mutationThe kidneys are centrally involved in the regulation of blood pressure. Kidney function requires the
coordinated actions of a number of different vascular and tubular cell types in the renal vasculature and in the
renal tubular system. The intrarenal coordination of these actions is not well understood. Since gap junctions
have been identiﬁed in the kidneys, possible pathways involved in this context could be direct intercellular
communication via gap junctions or via connexin hemichannels. In this context nine different connexins have
been found to be expressed in the kidney, either localized to the vasculature or to the tubular system.
Evidence is arising that malfunctions of certain connexins have an impact on the capability of the kidney to
maintain blood pressure homeostasis. Findings reported in this context will be outlined and discussed in this
review. This article is part of a Special Issue entitled: The Communicating junctions, composition, structure
and characteristics.he Communicating junctions,
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The kidney controls blood pressure by two main mechanisms,
namely by its capability to regulate salt and water excretion and by
regulating the activity of the renin angiotensin system. Since these
homeostatic renal functions require the interaction of different cell
types involved in, it is reasonable to consider cell to cell communi-cation in form of gap junctions or hemichannels in this context.
Hemichannels consisting of connexin sextamers form large conduc-
tance channels which enable the release of intracellular signal mole-
cules such as for example ATP into the extracellular space. Docking of
hemichannels of two neighbored cells leads to the formation of gap
junctions which allow the intercellular exchange of intracellular
signalingmolecules. The existence of gap junctionswithin the kidneys
has been demonstrated by electron microscopy already decades ago
[1–7]. In addition, nine members of the connexin protein family,
namely Cx26, Cx30.3, Cx31, Cx32, Cx37, Cx40, Cx43, Cx45, and Cx46
have been found to be expressed in the kidneys, at least at the mRNA
level [8–16] Thus, tubular gap junctions/hemichannels could be
CT/CD:  Cx30, Cx30.3
aTL: Cx30.3TALH: Cx37 
PT: Cx26, Cx32
G
ATP
Na+ Na+ Na+
Cx30
tubular urine flow rate
-
- -
PC PC PC
IC
A
B
Fig. 1. A. Model illustrating the potential role of Cx30 in the control of sodium
resorption in the connecting tubules (CT) and collecting ducts (CD). An increase of
tubular ﬂow rate as it occurs during enhanced salt intake causes the opening of Cx30
hemichannels in the luminal membrane of intercalated cells (IC) and the release of ATP.
ATP inhibits epithelial sodium channels (ENaC) in neighbored principal cells (PC) and
thus impairs sodium resorption during high salt intake. B. Distribution pattern of
connexins along the different nephron segments. G, glomerulus; PT, proximal tubule;
aTL, ascending thin limb oﬂoop of Henle; TALH, thick ascending limb of limb of Henle;
CT, connecting tubule; and CD, collecting duct.
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hemichannels could also be relevant for blood pressure control in
several ways. Firstly, they may inﬂuence renal blood ﬂow directed to
the glomeruli and thus inﬂuence glomerular ﬁltration, what in turn
may be relevant for salt resorption excretion and in consequence for
blood pressure. Secondly, gap junctions/hemichannels could be in-
volved in the signal transmission process along which macula densa
cells of the distal tubule communicate with the vascular smooth
muscle cells and with the renin secreting cells in the afferent arteriole
(tubuloglomerular communication). Finally, they may be directly
relevant for the function of renin secreting cells themselves. The
protease renin is the regulatory key element in the renin-angiotensin-
aldosterone (RAAS) cascade.
Since salt and water resorption take place in the tubular cells,
whereas the activity of the RAAS is controlled by the release of renin
from the vascular/juxtaglomerular area, it is of relevance to ﬁrst
consider the intrarenal localization pattern of connexins. More de-
tailed reviews about the expression pattern of connexins in the whole
kidney [17] and in special in the renal vasculature [18] and the
juxtaglomerular apparatus [19] have recently been provided, towhich
the reader is referred to.
2. Tubular connexins (Fig. 1)
2.1. The proximal tubule
The proximal tubule is the largest part of the nephron, which
resorbs more than 60% of the ﬁltered salt and water. Gap junctions
have been found in the proximal tubule (PT) [4,5]. Predominating
connexins in the PT are Cx26 [16,20,21] and Cx32 [16,20–22].Whether
the two connexins form heteromeric or exclusively homomeric
connexons, is yet unknown. The Cx 26/Cx32 coexpression pattern of
PT cells is very similar to pancreas, stomach and hepatocytes [16,23].
With the latter they show some special similarities such as the
capability of gluconeogenesis and of ammonium detoxiﬁcation. If and
how PT connexins could be relevant for salt and water resorption and
in consequence for blood pressure is yet unknown. If and how
proximal tubular connexin expression are physiologically regulated is
also unknown. Loss of function mutations of the two connexins have
not yet been associated with prominent changes of blood pressure in
humans. The same holds for Cx32 deﬁcient mice. Mice lacking Cx26
globally are not viable.Mice lackingCx26 speciﬁcally in PT have not yet
been reported.
2.2. The loop of Henle
Further 25% of the ﬁltered salt and water load are resorbed by the
loop of Henle. For this nephron segment gap junctions have not yet
been documented so far. However, evidence for expression of Cx30.3
in the thin ascending thin limbs of Henle has been provided [24,25].
The expression of Cx30.3 there appears to be insensitive towards
changes of salt intake and of changes of blood pressure [24]. If an
altered expression or activity of 30.3 connexons has inﬂuence on
blood pressure is not known. Cx30.3 knockout mice have a normal
blood pressure, arguing against a major role of this connexin in
blood pressure regulation [24]. The further downstream segment of
Henle's loop, the thick ascending limb, has recently been reported to
express Cx37 in the basolateral membrane [26]. Cx37 expression
there appears to be regulated by the salt intake in the way that it
increases during low salt diet and decreases during high salt diet,
what may be indicative of an adaptive tubular response to changes in
sodium reabsorption [26]. A link between tubular Cx37 expression
and blood pressure is not apparent, since Cx37 deﬁcient mice show no
obvious abnormalities with regard to blood pressure regulation [27].
Although a genetic polymorphism in the Cx37gene was suggested as a
prognostic marker for atherosclerotic plaque development, hyper-tension in humans has not yet been associated with mutations of the
Cx37 gene [28].
2.3. The distal nephron
A ﬁnal 10% of the ﬁltered salt and water load are resorbed by the
distal tubule and the collecting duct system. In this nephron segment
no gap junctions have been documented so far. The distal connecting
tubule and the collecting duct consist of two cell types, principal cells
and intercalated cells, which mediate salt/water resorption and acid/
base secretion, respectively. Good evidence exists to indicate that
intercalated cells express Cx30 and Cx30.3 in the nonjunctional apical
membrane [24,29]. Cx30 hemichannels there appear to be mechan-
osensitive and to mediate release of ATP from the intercalated cells
into the tubular ﬂuid in response to increased tubular urine ﬂow [30].
Released ATP, in turn, inhibits the amiloride sensitive epithelial
sodium channel ENaC in principal cells and thus inhibits sodium
resorption in the collecting duct [31]. Along these events Cx30
hemichannels could play a relevant role for the adjustment of the
body to changes of oral salt intake (Fig. 1A). An increased salt load
requires an increased tubular ﬂow rate in combination with a reduced
activity of ENac to excrete the increased sodium load. Exactly this link
could be provided by Cx30 hemichannels, the expression of which is
also increased during high salt intake [29]. In line, mice lacking Cx30,
fail to adjust renal sodium excretion to increased sodium intake and
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renal intercalated cells could be an important player in the regulation
of blood pressure, in particular by preventing salt sensitive hyper-
tension, which occurs in about 40% of human hypertensive patients.
Mutations in the human Cx30 and Cx30.3 genes have been
associated with skin diseases such erythrokeratodermia variabilis and
Clouston syndrome (for rev. see [32]). Whether those patients in
general also suffer from dysregulation of blood pressure is unknown.
Deletion of Cx30 and of Cx30.3 in mice does not produce a skin
phenotype [32]. Cx30.3 knockout mice have normal blood pressure.
As already mentioned Cx30 deﬁcient mice have normal blood pres-
sure under normal salt diet and develop hypertension under high salt
intake.
3. Vascular connexins
3.1. Distribution of connexins in the kidney vasculature (Fig. 2)
The kidney vasculature displays a special architecture designed to
deliver blood to the glomeruli, which are the site of plasma ultra-
ﬁltration. Each of the numerous glomeruli has its own feeding
arteriole, named afferent arteriole. Afferent arterioles branch off from
the larger interlobular arteries, which in turn, originate from arcuate
arteries. These result from branching of large interlobular arteries
which ﬁnally represent the branches of the renal artery. In mice, rats
and rabbits, in which systematic analyses have been performed so far,
all segments of this so-called preglomerular arteriolar tree show a
typical expression pattern of connexins (Fig. 2), in the way, that the
endothelium expresses Cx37 and Cx40 [12,33,34], while the smooth
muscle layer expresses Cx45 [33,35,36]. Cx43 is found in the endo-
thelium of preglomerular and postglomerular arteriolar tree and in
the endothelium of renal veins [33,34]. At the terminal parts of the
afferent arterioles at the junction to the glomerular capillary network
the smooth muscle cell layer is replaced by the secretory renin
producing cells which form a cellular continuum with extraglomer-
ular mesangial (EGM) cells (Fig. 2). Renin secreting mainly express
Cx40 and to a lesser extent Cx37 [12,33,34]. Whether they also con-
tain Cx45 is a matter of controversy [35,37]. Cx40 expression is also
conﬁrmed for extraglomerular mesangial (EGM) cells, while conﬂict-
ing data exist regarding the expression of Cx37 and of Cx45 in theseVSMC: Cx45 
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Fig. 2. Distribution pattern of connexins in the renal vasculature and (juxta)glomerular
region. G, glomerulus; interlob. art., interlobular artery, aff.art., afferent arteriole; eff.
art., efferent arteriole; EC, endothelial cells; VSMC, vascular smooth muscle cells; RSC,
renin secreting cells; mes, mesangial cells, MD, macula densa cells of distal tubule;
podo, podocytes; Question marks indicate that connexins have not yet been localized in
normal kidneys.cells [33,35,38]. Within the glomeruli the intraglomerular mesangial
cells express mainly Cx40 [33,34] and eventually Cx45 [35].
Glomerular Cx37 immunoreactivity is conﬁned to the vascular pole
[12,33,38,39], suggesting an expression of Cx37 in endothelial cells
and/or mesangial cells at the extra- to intraglomerular junctions.
For normal podocytes no convincing evidence for the expression of
connexins has been provided so far. These connexin expression
patterns in the (juxta)glomerular region ﬁt well with the high density
of gap junctions in this area, which has been demonstrated by electron
microscopy already more than 2 decades ago. The efferent arterioles
draining blood from the glomeruli express Cx43 in the endothelium
[34] and Cx45 in smooth muscle cells [33,35,36].
3.2. Connexin 43
In the context of blood pressure regulation it has been reported that
global replacement of Cx43 by Cx32 leads to lower circulating renin
concentrations which are associated with slightly lowered blood
pressure levels [22]. The number of renin expressing cells in these
kidneys also appears to be reduced. Most notably, however, unilateral
renal artery stenosis which is a classic situation for stimulating renin
synthesis and renin secretion [40] and which leads to systemic hyper-
tension, fails to do so in animals, in which Cx43 is globally replaced by
Cx32 [22]. This ﬁnding suggests that the renal baroreceptormechanism
that mediates a negative feedback control of renin secretion by the
blood pressure [40] is nonfunctioning in thesemice. The explanation for
this interesting phenomenon, however, is more difﬁcult, because Cx43
is expressed in the endothelium of afferent arterioles rather than in
renin producing cells themselves [38]. Mice with deletion of endo-
thelial Cx43 have been reported to be either normotensive [41] or
even hypotensive [42]. In the latter report the fall of blood pressure
was associated with an apparently intact stimulation of renin secretion
[42] — i.e. the baroreceptor mechanism controlling renin secretion is
intact in thesemice. Therefore the effect of replacement of Cx43byCx32
on the renin system is probably indirect rather than direct. This
assumption is supported by the report that intrarenal infusion of Cx43
mimetic peptides exerted no inﬂuence on renin secretion nor blood
pressure [38]. The detailed mechanisms underlying the effect of sub-
stitution of Cx43 by Cx32 on the renin system therefore awaits clari-
ﬁcation. Unfortunately, micewith global Cx43 deletion die in utero [43]
and are therefore not available to study the control of the renin system.
An alternative approach could be the analysis of renin cell speciﬁc
deletion of Cx43. Those experiments are currently underways in our
laboratory.
3.3. Connexin 37
Mice lacking connexin 37, which is well expressed in the
preglomerular endothelium [34,38,44] and in the renin secreting
cells [33,34], show no abnormalities with regard to ambient blood
pressure [27]. In line, basal and pressure regulated renin secretion
from the kidneys in vivo and in vitro are normal in Cx37 deﬁcientmice
[45]. Also renal blood ﬂow appears to be normal in these animals (Just
A. pers comm.). These ﬁndings, however, are in conﬂict with a study
reporting an acute effect of intrarenal infusion of Cx37 mimetic
peptides on renal blood ﬂow, renin secretion and blood pressure [38].
Thus, infusion of the peptide caused an almost immediate fall of renal
perfusion, an enhancement of renin secretion and consequently of
blood pressure in the rat. This discrepancy cannot be explained at the
moment unless that in Cx37 deﬁcient mice the loss of potential Cx37
regulatory function in renin producing cells might have been
compensated during development and might appear therefore only
during acute pharmacological block of Cx37 gap junctions. If so, the
physiological role of Cx37 would be to inhibit renin secretion and in
consequence to lower blood pressure.
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An inhibitory function on renin secretion is meanwhile clearly
established for Cx40 connexons for which studies with acute blockade
with gap junction mimetics and with Cx40 knockout animals agree
upon. Intrarenal infusion of Cx40 blocking peptides acutely enhances
renin secretion and blood pressure [38,46]. In line, Cx40 deﬁcient
mice are hyperreninemic and hypertensive [47,48]. Cx40 blocking
peptides also acutely increase renovascular resistance [38,46], what,
however, is not seen in Cx40 deﬁcient mice, which have normal renal
perfusion [49]. However, the characteristic autoregulation of renal
blood ﬂow is clearly impaired in Cx40 deﬁcient mice [49,50] meaning
that ﬂow changes of renal perfusion towards pressure changes are
more pronounced in Cx40 deﬁcient mice. The leading feature of Cx40
deﬁcient mice is prominent hypertension [51], that results from an
enhanced release of renin from the kidneys what causes over-
activation of the renin angiotensin aldosterone system [47,48]. Nor-
mally, elevated blood pressure should suppress renin secretion from
the kidneys in the sense of a negative feedback to enable the main-
tenance of normal and stable blood pressure. This pressure control of
renin secretion is clearly defective in the absence of Cx40. Instead of a
normal inverse relationship between renal perfusion pressure and
renin secretion is this relationship changed to an almost linear
positive relationship in the absence of Cx40 [47,52] (Fig. 3). Selective
deletion of Cx40 in renin producing cells exactly mimics the pheno-
type of global Cx40 deletion, whereas endothelial deletion of Cx40
had no effect on renin secretion [52]. These ﬁndings suggest that it is
not a disruption of gap junctional coupling between endothelial and
renin secreting cells that produces the special phenotype. In turn, one
may infer that gap junctional coupling between EC and RC is not a
major component of the renal baroreceptor mechanism controlling
renin secretion. In principle, the effects induced by deletion of the
Cx40 protein must not exclusively be caused by impaired gap junc-
tional coupling but could instead also be due to a loss of an important
scaffold function of the Cx40 protein. In fact, Cx40 protein associates
with eNOS [50], probably Cx37 and likely other proteins. Recently a
loss of function mutation of connexin 40 (Cx40 A96S), with sub-
stantially impaired pore function was recently discovered in humans
[53]. Introducing the same mutation in the mouse Cx40 gene leads to
poorly conducting gap junctions, which however, are found to be
localized in the kidney in very similar distribution pattern to the
wildtype proteins [54]. The renin phenotype of Cx40A96S mice,normal Cx40 function 
defective Cx40 function
renin
secretion
renal artery pressure
N
Fig. 3. Schematic illustration of the relationship between renal artery pressure and
renin secretion from isolated perfused mouse kidneys. Normally renin secretion is
inversely related to the renal perfusion pressure. If Cx40 function in renin secreting cells
is defective, the inverse relationship turns to an almost linear relationship between
perfusion pressure and renin secretion. N indicates normal pressure (100 mm Hg).however, is very similar to that of mice lacking the Cx40 completely
[54]. This observation supports the assumption that the pore function
of Cx40 connexons is important for regulating the function of renin
secreting cells rather than a possible membrane anchor function of
the protein. This conclusion raises the question about the relevant
signals passing Cx40 connexons and about the cells with which renin
producing cells communicate via Cx40 connexons. Connexin hemi-
channels have been proposed to contribute to intercellular signaling
in the juxtaglomerular area [55,56]. In view of the dense gap
junctional coupling of renin secreting cells in situ [1,2] and of
immortalized renin secreting cells in vitro [57], however, it appears
likely that the intercellular communication in situ occurs mainly via
Cx40 gap junctions rather than via Cx40 hemichannels. In principle,
renin producing cells could form Cx40 gap junctions among each
other and together with extra- and intraglomerular mesangial cells
(Fig. 4A). Which of these are relevant for the control of renin secretion
by the blood pressure, is presently unknown. It is of note, that renin
secreting cells with defective 40 gap junctional coupling are
ectopically localized in the periglomerular interstitium instead of
their normal position in the media layer [52,54,58] (Fig. 4). This
abnormal localization suggests that renin producing cells probably
receive signals via Cx40 gap junctions from their neighbored cells to
deﬁne their correct position. The ectopic position of renin secreting
cells could provide one explanation why renin secretion is not
anymore sensitive to the renal perfusion pressure, because the
ectopically located cells won't be able to sense a transmural wall
tension. The stimulatory effect of gap junction blockers on renin
secretion from kidneys of normal animals, however, would suggest,
that Cx40 gap junctions also have a direct role in transducing blood
pressure to renin secretion. Two lines of indirect evidence suggest that
calcium might be a relevant signal passing Cx40 gap junctions in the
control of renin secretion. Firstly, a very similar change of the
relationship between renal perfusion pressure and renin secretion as
seen in the absence of Cx40 is seen, if the kidneys are perfused with
solutions that contain a low calcium concentration [59]. Secondly, the
prominent stimulation of renin secretion induced by lowering the
calcium concentration in the kidney perfusate [60] ultimately requires
the presence of Cx40 [47,52]. It is known that Cx40 gap junctions are
permeable for calcium and a role of Cx40 gap junctions in the
intercellular spreading in cells of the juxtaglomerular area has already
been discussed [55,56].
Altogether, Cx40 gap junctions in the kidney appear to be highly
relevant for a proper control of renin secretion and in consequence of
blood pressure. The above mentioned data were all obtained in expe-
rimental animals raising the question about the potential relevance in
humans.
It has been shown previously that the connexin distribution
pattern in the human kidney is very similar to that of mice and rats.
This holds particularly true for Cx40which is strongly expressed in the
human mesangium and renin producing cells [39]. In addition, a
discovered loss of function mutation recently in humans produces
hyperreninemia and hypertension in mice [53,54]. The patient, in
which the mutation was originally discovered, was also hypertensive
(GollobM, personal communication). Furthermore, polymorphisms in
the human Cx40 gene promoter have been suggested to increase the
susceptibility for hypertension [61]. It will be worthwhile therefore, to
consider loss of function mutations of the Cx40 as possible reasons for
unexplained hypertension in future.
3.5. Connexin 45
Finally, a possible relevance role of renal Cx45 for blood pressure has
to be discussed. Cx45 is expressed by the media layer of the
preglomerular vascular tree, where it provides-if at all- only a weak
electrical coupling between the smooth muscle cells [62]. If renin
producing cells which form the media layer of the terminal parts of
IGM
Podocytes
IGM
Podocytes
EGM
EGM
Bowman capsule
VSMC
EC
RSC
A
B
Fig. 4. Sketch summarizing the localization and morphology of the renin secreting cells in kidneys with normal (A) and with defective (B) of Cx40 function. Red cylinders indicate
Cx40 gap junctions with renin secreting cells. EC, endothelial cells; VSMC, vascular smooth muscle cells; RSC, renin secreting cells; IGM, intraglomerular mesangial cells; and EGM,
extraglomerular mesangial cells.
1907A. Kurtz / Biochimica et Biophysica Acta 1818 (2012) 1903–1908afferent arterioles also express Cx45 is a matter of debate [35,37]. The
same holds for their possible relevance in the control of renin secretion
and in consequence of blood pressure. Mice generated by interbreeding
strains harboring ﬂoxed Cx45 alleles together withmice that drive Cre-
recombinase under the control of the endogenous renin promoter
should be expected to be devoid of Cx45 in renin producing cells. Those
mice have a normal blood pressure and they display normal regulation
of renin secretion [37], suggesting that renal Cx45 does not play an
important role for renin secretion and for the control of blood pressure.
These results, however, are conﬂicted by data obtained with mice that
were generated by crossing mice with Cx45 ﬂoxed alleles with mice
drivingCre-recombinase under the control of nestin.Nestin is expressed
by a variety of tissues including the developing kidney vasculature [63].
It was found that these mice have elevated blood pressure values and
elevated plasma renin concentrations [35]. Pressure control of renin
secretion was not analyzed in these animals. Therefore, it cannot be
excluded in view of the wide expression pattern of nestin, that the
effects observed in these animals were indirect rather than directly
mediated by an altered function of renin producing cells.4. Summary and perspectives
There is accumulating evidence that connexin function in the kidney
is relevant for blood pressure regulation. Firstly, Cx30 hemichannels in
the luminalmembrane of intercalated cells in the collecting duct system
appear to play an indirect regulatory role for sodium resorption in the
collecting duct. Loss of function mutations of Cx30 might render
individuals susceptible to salt dependent hypertension. Secondly, Cx40
gap junctions appear to be highly relevant for a correct function of renin
secreting cells, in particular, for the feedback control of renin secretion
by the blood pressure. Therefore loss of function mutation of Cx40
connexinsmight be one yet underestimated reason for renin dependent
hypertension. Future analyses in human hypertensive patients will berequired to deﬁne the etiological relevance of Cx30 and of Cx40 muta-
tions as causes of hypertension.
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